ENDRA Life Sciences's total assets for Q1 2025 were $3.17M, a decrease of -28.79% from the previous quarter. NDRA total liabilities were $1.42M for the fiscal quarter, a -25.07% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.